Madison N. Behm

Madison N. Behm

Auto-generated profile, based on publicly available information

Madison N. Behm

Division of Cancer Control and Population Sciences, United States National Cancer Institute, Rockville, MD

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
DDDanielle Daee
Danielle Daee
MBMadison Behm
Madison Behm
PMPamela M. Marcus
Pamela M. Marcus
SRSonia M. Rosenfield
Sonia M. Rosenfield
MRMelissa Rotunno
Melissa Rotunno
EGElizabeth M. Gillanders
Elizabeth M. Gillanders
The secondary use of data can accelerate innovation and drive discoveries, tool development, and reproducibility. Though data sharing can be challenging, policies and incentives can help facilitate and reward these efforts. To maximize the value of data produced through NIH awards, the NIH recently set forth comprehensive, modern data sharing requirements for all funded research with the 2023 NIH Data Management and Sharing Policy. In light of this new comprehensive policy, the NCI’s Division of Cancer Control and Population Sciences (DCCPS) saw an opportunity to reward exemplary data sharers and add an incentive for future data sharing through the development of an award. In 2024, DCCPS established the “Paul Fearn Award for Excellence in Data Sharing” to promote recognition and celebrate data sharing within the field of population sciences. In its inaugural year, the award was given to researchers from four different projects, each exemplary in the sharing of DCCPS-funded work. Each awardee went above and beyond data sharing requirements to make data reusable for others. Their distinct data sharing achievements included making valuable historical datasets available, preparing accessible and easily downloadable datasets, and developing a novel data enclave and/or researcher data platform.

1 August 2026 in JCO Global Oncology
Verified
Journal Article
Open access
RHRachel A. Hanisch
Rachel A. Hanisch
SQSarah Quesnel-Crooks
Sarah Quesnel-Crooks
LELinsey Eldridge
Linsey Eldridge
ACAnn Chao
Ann Chao
MBMadison N. Behm
Madison N. Behm
ALAlicia A. Livinski
Alicia A. Livinski
PURPOSE: To conduct a scoping review to identify publications that used data from Caribbean cancer registries (CRs) to characterize the type of information disseminated and identify knowledge gaps. METHODS: We searched PubMed, Scopus, Web of Science: Core Collection and SciELO, and Latin American and Caribbean Literature on Health Sciences for articles published in English, French, Dutch, or Spanish between January 2012 and May 2023. Articles that used data from a CR located in one or more Caribbean country/territory were included. In Covidence, a two-step screening process at title/abstract and full text was completed by two reviewers independently. Data were extracted from each included article independently by two reviewers using Covidence. A gray literature search of online and paper reports using CR data was also conducted to supplement the literature searches. RESULTS: A total of 126 articles met the inclusion criteria and reported CR data from 1958 to 2018. Of the 33 Caribbean countries/territories included, 12 had at least one publication. Most publications (95%) used data from population-based CRs (PBCRs). Three countries/territories with PBCRs had <3 publications, and three had none. Breast, cervical, and colorectal were the most reported cancers. Ten of 14 (71%) countries/territories with a PBCR had at least one cancer incidence report available from the past 5 years. CONCLUSION: Caribbean CRs have contributed substantially to the peer-reviewed literature, but this is limited to fewer than half of the Caribbean countries and primarily those with a PBCR. Efforts are needed to establish and support PBCRs to produce high-quality data and to bridge the gap between the collection and dissemination of CR data to address key knowledge gaps, prioritize research questions, and inform cancer control policies.